A Decline in Cognitive Function Should Lead to a Change in Disease-Modifying Therapy – Yes

Multiple Sclerosis - United States
doi 10.1177/1352458518783364
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

SAGE Publications

Related search

A Decline in Cognitive Function Should Lead to a Change in Disease-Modifying Therapy – Commentary

Multiple Sclerosis
Neurology
2018English

A Decline in Cognitive Function Should Lead to a Change in Disease-Modifying Therapy – No

Multiple Sclerosis
Neurology
2018English

Prm115 - Modeling Decline in Cognition to Decline in Function in Alzheimer’s Disease (Ad)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Should Disease-Modifying Therapy Be Stopped in Patients With Rheumatoid Arthritis Before Endoprosthetic Joint Replacement?

Nauchno-Prakticheskaya Revmatologiya
RheumatologyAllergyImmunology
2011English

Health Status Decline in Α-1 Antitrypsin Deficiency: A Feasible Outcome for Disease Modifying Therapies?

Respiratory Research
PulmonaryRespiratory Medicine
2018English

Should Geriatric Medicine Remain a Specialty? Yes

BMJ
2008English

Association Between Visual Impairment and Decline in Cognitive Function in a Multiethnic Asian Population

JAMA network open
Medicine
2020English

Quantitative EEG and Cognitive Decline in Parkinson’s Disease

Parkinson's Disease
PsychiatryNeuroscienceMental HealthNeurology
2016English

Rescue Therapy for Refractory ARDS Should Be Offered Early: Yes

Intensive Care Medicine
Critical CareIntensive Care Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy